Literature DB >> 30642948

Germ Line Deletion Reveals a Nonessential Role of Atypical Mitogen-Activated Protein Kinase 6/Extracellular Signal-Regulated Kinase 3.

A Kotlyarov1, M Gaestel2, N Ronkina1, K Schuster-Gossler3, F Hansmann4, H Kunze-Schumacher5, I Sandrock6, T Yakovleva1, J Lafera1, W Baumgärtner4, A Krueger5, I Prinz6, A Gossler3.   

Abstract

Mitogen-activated protein kinase 6/extracellular signal-regulated kinase 3 (MAPK6/ERK3) is an atypical member of the MAPKs. An essential role has been suggested by the perinatal lethal phenotype of ERK3 knockout mice carrying a lacZ insertion in exon 2 due to pulmonary dysfunction and by defects in function, activation, and positive selection of T cells. To study the role of ERK3 in vivo, we generated mice carrying a conditional Erk3 allele with exon 3 flanked by loxP sites. Loss of ERK3 protein was validated after deletion of Erk3 in the female germ line using zona pellucida 3 (Zp3)-cre and a clear reduction of the protein kinase MK5 is detected, providing the first evidence for the existence of the ERK3/MK5 signaling complex in vivo In contrast to the previously reported Erk3 knockout phenotype, these mice are viable and fertile and do not display pulmonary hypoplasia, acute respiratory failure, abnormal T-cell development, reduction of thymocyte numbers, or altered T-cell selection. Hence, ERK3 is dispensable for pulmonary and T-cell functions. The perinatal lethality and lung and T-cell defects of the previous ERK3 knockout mice are likely due to ERK3-unrelated effects of the inserted lacZ-neomycin resistance cassette. The knockout mouse of the closely related atypical MAPK ERK4/MAPK4 is also normal, suggesting redundant functions of both protein kinases.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  MAPKAPK5/MK5; gene deletion; mitogen-activated protein kinases; protein kinase

Mesh:

Substances:

Year:  2019        PMID: 30642948      PMCID: PMC6399663          DOI: 10.1128/MCB.00516-18

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

1.  Regulation of Zap70 expression during thymocyte development enables temporal separation of CD4 and CD8 repertoire selection at different signaling thresholds.

Authors:  Manoj Saini; Charles Sinclair; Daniel Marshall; Mauro Tolaini; Shimon Sakaguchi; Benedict Seddon
Journal:  Sci Signal       Date:  2010-03-23       Impact factor: 8.192

2.  ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.

Authors:  Weiwen Long; Charles E Foulds; Jun Qin; Jian Liu; Chen Ding; David M Lonard; Luisa M Solis; Ignacio I Wistuba; Jun Qin; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

3.  The atypical MAPK ERK3 controls positive selection of thymocytes.

Authors:  Julien Sirois; Jean-François Daudelin; Salix Boulet; Miriam Marquis; Sylvain Meloche; Nathalie Labrecque
Journal:  Immunology       Date:  2015-05       Impact factor: 7.397

4.  Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death.

Authors:  T Braun; M A Rudnicki; H H Arnold; R Jaenisch
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

5.  Docking of PRAK/MK5 to the atypical MAPKs ERK3 and ERK4 defines a novel MAPK interaction motif.

Authors:  Espen Aberg; Knut Martin Torgersen; Bjarne Johansen; Stephen M Keyse; Maria Perander; Ole-Morten Seternes
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

6.  Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5.

Authors:  Paul Déléris; Justine Rousseau; Philippe Coulombe; Geneviève Rodier; Pierre-Luc Tanguay; Sylvain Meloche
Journal:  J Cell Physiol       Date:  2008-12       Impact factor: 6.384

7.  Comparative Analysis of Two Gene-Targeting Approaches Challenges the Tumor-Suppressive Role of the Protein Kinase MK5/PRAK.

Authors:  Natalia Ronkina; Claus Johansen; Lisa Bohlmann; Juri Lafera; Manoj B Menon; Christopher Tiedje; Kathrin Laaß; Benjamin E Turk; Lars Iversen; Alexey Kotlyarov; Matthias Gaestel
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

8.  High-efficient FLPo deleter mice in C57BL/6J background.

Authors:  Yingjie Wu; Chunxin Wang; Hui Sun; Derek LeRoith; Shoshana Yakar
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240

9.  The non-classical MAP kinase ERK3 controls T cell activation.

Authors:  Miriam Marquis; Salix Boulet; Simon Mathien; Justine Rousseau; Paméla Thébault; Jean-François Daudelin; Julie Rooney; Benjamin Turgeon; Claudine Beauchamp; Sylvain Meloche; Nathalie Labrecque
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  Transcriptome Analysis of Targeted Mouse Mutations Reveals the Topography of Local Changes in Gene Expression.

Authors:  David B West; Eric K Engelhard; Michael Adkisson; A J Nava; Julia V Kirov; Andreanna Cipollone; Brandon Willis; Jared Rapp; Pieter J de Jong; Kent C Lloyd
Journal:  PLoS Genet       Date:  2016-02-03       Impact factor: 5.917

View more
  2 in total

1.  ERK3/MAPK6 controls IL-8 production and chemotaxis.

Authors:  Katarzyna Bogucka; Malvika Pompaiah; Federico Marini; Harald Binder; Gregory Harms; Manuel Kaulich; Matthias Klein; Christian Michel; Markus P Radsak; Sebastian Rosigkeit; Peter Grimminger; Hansjörg Schild; Krishnaraj Rajalingam
Journal:  Elife       Date:  2020-04-21       Impact factor: 8.140

2.  FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells.

Authors:  Hyun-Jung An; Cheol-Jung Lee; Ga-Eun Lee; Youngwon Choi; Dohyun Jeung; Weidong Chen; Hye Suk Lee; Han Chang Kang; Joo Young Lee; Dae Joon Kim; Jin-Sung Choi; Eun Suh Cho; Jong-Soon Choi; Yong-Yeon Cho
Journal:  Exp Mol Med       Date:  2022-01-12       Impact factor: 12.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.